Dr. Margaret Hamburg on the Promise of CPTR

From the launch of the CPTR Initiative, Dr. Hamburg speaks on the need for new TB drugs, her previous experience dealing with an MDR-TB epidemic in New York City, the promise of CPTR, and FDA\'s desire to act as a "gateway" and not a barrier to the development of new and improved TB treatment regimens. Introduction by Dr. Mel Spigelman, CEO, TB Alliance.